VR Logo

ADMA Biologics Inc (ADMA) download report


Healthcare | Biotechnology & Pharma Research

ADMA Biologics Inc (ADMA) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

IPO Date: 17-Oct-2013

Co-Founder, Pres, CEO & Director: Mr. Adam S. Grossman

Co-Founder & Vice Chairman: Dr. Jerrold B. Grossman D.P.S., Ph.D.

Listing: NASDAQ: ADMA

Country: United States

Headquarters: Ramsey, NJ

Website: https://www.admabiologics.com

Key Facts

Market cap: $384.85 Mln

Revenue (TTM): $55.49 Mln

Earnings (TTM): $-78.28 Mln

Cash: $69.50 Mln

Total Debt: $146.36 Mln

Insider's Holding: 2.11%

Liquidity: Low

52 Week range: $1.01 - 2.31

Shares outstanding: 196,352,000

10 Years Aggregate:

  • CFO: $-456.70 Mln
  • EBITDA: $-339.89 Mln
  • Net Profit: $-382.30 Mln

Stock Performance

Time Period ADMA Biologics (ADMA) S&P BSE Sensex S&P Small-Cap 600
YTD43.97-9.18-18.78
1 month-0.49-4.78-8.00
3 months10.93-9.66-13.65
1 Year26.880.81-17.19
3 Years-19.3510.336.10
5 Years-11.3111.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year ADMA Biologics (ADMA) S&P Small-Cap 600 S&P BSE Sensex
2021-27.6925.2721.99
2020-51.259.5715.75
201967.3620.8614.38
2018-25.43-9.705.87
2017-37.3011.7327.91
2016-36.5624.741.95
2015-27.75-3.36-5.03